Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

NCT02187991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast Carcinoma
Breast Tumors
Malignant Neoplasm of Breast

Interventions

DRUG: Paclitaxel
DRUG: Alisertib

Sponsor

US Oncology Research

Collaborators

[object Object]